JEDI BILLION MOLECULES AGAINST COVID19 GRANDCHALLENGE

Screening billions of possible molecular compounds that can block SARS-CoV-2

​THE GRANDCHALLENGE

shubham-dhage-fmCr42xCLtk-unsplash.jpg

Improve (in silico or others) methods to identify compounds with blocking interactions relevant to any SARS-CoV-2 target, by optimizing/accelerating the use of HPC (High Performance Computing), Artificial Intelligence, and provide experimental validation.

The uniqueness of this JEDI GrandChallenge is to push for (i) modelling a number of active molecules at a scale never seen before (ii) the determination of a highly accurate list of active compounds cross-correlated by the teams all over the world, (iii) ultra fast-track in-vitro identification of molecules with 2-log reduction in viral activity and (iv) identifying the best drug-cocktail out of existing FDA-approved molecules.

An estimated 54 billion molecules have been screened by 130 teams, representing more than 500 scientists coming from the best institutions in the world.

As of February 20, 2021, 878 of the most promising molecules have been synthetized, compounds that didn't exist in any molecular library in the world. This is an immense and quasi unprecedented endeavor.

These top scoring compounds will be analyzed experimentally using direct affinity assays, as well as viral assays, with live SARS-CoV-2, in top laboratories in Germany, France and the United States.

54 billion molecules
130 teams
500 scientists
ONE CHALLENGE

54 billion molecules scanned!

130 Participating Teams to the JEDI Covid19 GrandChallenge

Group 44.png
PM.png

Program Manager

Prof. Thomas M. Hermans

Thomas Hermans is professor in Chemistry at the University of Strasbourg and group leader of the Laboratory of Nonequilibrium Complex Systems (www.hermanslab.com).

He received the ERC Starting Grant 2017, Thieme Chemistry Award 2018, Prix Guy Ourisson 2018, and is a Young Scientist at World Economic Forum and the World Laureates Association.

SCIENTIFIC COMMITTEE

image 3.png

Prof. Gregory Bowman

Director Folding@home and Associate Professor at Washington University in St. Louis.

image 4.png

Prof. Charles L. Brooks III

Research Group Leader, Department of Chemistry and Biophysics Program, University of Michigan

image 5.png

Prof. John Chodera

Research Group Leader at the Memorial Sloan-Kettering Cancer Center, Member of the project for simulating protein dynamics Folding@home

image 6.png

Prof. Babak Falsafi

Prof. Babak Falsafi Computer architecture, founder and director of the consortium EcoCloud,  Professor in Computer Sciences, Ecole Polytechnique Fédérale de Lausanne (EPFL)

image 20.png

Prof. Bryan Ford

Associate Professor and Head of the Decentralized and Distributed Lab of the Ecole Polytechnique Fédérale de Lausanne (EPFL)

image 8.png

Prof. Adolfo Garcia-Sastre

Director of the Global Health and Emerging Pathogens Institute, Mount Sinai

image 21.png

Dr. Marion Guillou

Former Chief Executive Officer (CEO) of the Institut National de la Recherche Agronomique (INRA) and former chairwoman of Ecole Polytechnique

image 10.png

Prof. Marion Koopmans

Member of the advisory panel on COVID-19 of the European Commission, Director of a WHO collaborating center, and Head of the department of Viroscience, Erasmus Medical Center

image 23.png

Prof. Sang-Yup Lee

Director of the Bioinformatics Research Center, Korean Advanced Institute for Science and Technology

image 12.png

Dr. Nadia Naffakh

Head of the RNA Biology of Influenza Viruses Unit, Institut Pasteur-CNRS

image 13.png

Sir Peter Ratcliffe

Director of Clinical Research at the Francis Crick Institute and Nobel Laureate 2019 in Physiology or Medicine

image 14.png

Dr. Stephane Requena

Innovation and Technology Director, French HPC network GENCI

image 15.png

Prof. Bernhard Schoelkopf

Head of Department Empirical Inference
Max Planck Institute for Intelligent Systems

image 16.png

Prof. Fabian Theis

Head of the Institute of Computational Biology and Research Group Leader, Helmholtz Zentrum Munich

image 17.png

Prof. Alexandre Varnek

Head of the Laboratory of Cheminformatics, University of Strasbourg

image 18.png

Dr. Daniel Verwaerde

Current CEO of Teratec and former CEO of the Commissariat à l’Energie Atomique et aux énergies alternatives (CEA)